ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, l-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats

Vascular Pharmacology

Volumn 44, Issue 6, 2006, Pages 491-507

  Lewis, Stephen J ^a   Hashmi Hill, Maleka P ^a   Owen, Joy R ^a   Sandock, Kevin ^a   Robertson, Tom P ^a   Bates, James N ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin converting enzyme; Hemodynamics; Nitric oxide; S nitrosothiols; Spontaneously Hypertensive rats (SHR)

Indexed keywords

1 N METHYL N [6(N METHYLAMMONIOHEXYL)AMINO] DIAZEN 1 IUM 1,2 DIOLATE; ACETYLCHOLINE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRALAZINE; NITRIC OXIDE DONOR; NITROSOCYSTEINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; ENZYME ACTIVITY; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; CAPTOPRIL; CYSTEINE; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; FEMORAL ARTERY; GLUTATHIONE DISULFIDE; HYDRALAZINE; HYPERTENSION; MALE; NITRIC OXIDE DONORS; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; S-NITROSOTHIOLS; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 33646788410     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.03.003     Document Type: Article

References (95)

1. Adeagbo A.S., Joshua I.G., Falkner C., and Matheson P.J. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. Eur. J. Pharmacol. 481 (2003) 91-100
2. + channels in resting state of carotid arteries from SHR. Am. J. Physiol. 265 (1993) H843-H851
3. Batenburg W.W., De Vries R., Saxena P.R., and Danser A.H. l-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries?. J. Hypertens. 22 (2004) 927-936
4. Batenburg W.W., Popp R., Fleming I., De Vries R., Garrelds I.M., Saxena P.R., and Danser A.H. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?. Brit. J. Pharmacol. 142 (2004) 125-135
5. Bolotina V.M., Najibi S., Palancino J.J., Pagano P.J., and Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
6. Bolterman R.J., Manriquez M.C., Ortiz Ruiz M.C., Juncos L.A., and Romero J.C. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46 (2005) 943-947
7. Borek M., Charlap S., and Frishman W. Enalapril: a long-acting angiotensin-converting enzyme inhibitor. Pharmacotherapy 7 (1987) 133-148
8. Bradford M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-253
9. Cabassi A., Dumont E.C., Girouard H., Bouchard J.F., Le Jossec M., Lamontagne D., Besner J.G., and de Champlain J.J. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. Hypertension 19 (2001) 1233-1244
10. 1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function?. Am. J. Physiol. 285 (2003) R674-R681
11. Chen S.R., Eisenach J.C., and Pan H.L. Intrathecal S-nitroso-N-acetylpenicillamine and l-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience 101 (2000) 759-765
12. Cheng S.W., Swords B.H., Kirk K.A., and Berecek K.H. Baroreflex function in lifetime-captopril-treated spontaneously hypertensive rats. Hypertension 13 (1989) 63-69
13. Clozel M., Kuhn H., and Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16 (1990) 532-540
14. Colombari E., Davisson R.L., Shaffer R.A., Talman W.T., and Lewis S.J. Hemodynamic effects of l-glutamate in NTS of conscious rats: a possible role of vascular nitrosyl factors. Am. J. Physiol. 274 (1998) H1066-H1074
15. Cuzzocrea S., Mazzon E., Dugo L., Di Paola R., Caputi A.P., and Salvemini D. Superoxide: a key player in hypertension. FASEB J. 18 (2004) 94-101
16. Danser A.H., De Vries R., Schoemaker R.G., and Saxena P.R. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors. J. Hypertens. 16 (1998) 239-244
17. Davisson R.L., Johnson A.K., and Lewis S.J. Nitrosyl factors mediate active neurogenic hindquarter vasodilation in the conscious rat. Hypertension 23 (1994) 962-966
18. Davisson R.L., Bates J.N., Johnson A.K., and Lewis S.J. Use-dependent loss of acetylcholine- and bradykinin-mediated after nitric oxide synthase inhibition: evidence for preformed stores of nitric oxide-containing factors in vascular endothelial cells. Hypertension 28 (1996) 354-360
19. Davisson R.L., Shaffer R.A., Johnson A.K., and Lewis S.J. Use-dependent loss of active sympathetic neurogenic vasodilation following NO synthase inhibition in conscious rats: evidence for the presence of preformed stores of NO-containing factors. Hypertension 28 (1996) 347-353
20. Davisson R.L., Shaffer R.A., Johnson A.K., and Lewis S.J. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors. Neuroscience 72 (1996) 881-887
21. Davisson R.L., Travis M.D., Bates J.N., and Lewis S.J. Hemodynamic effects of l- and d-S-nitrosocysteine in the rat: stereoselective S-nitrosothiol recognition sites. Circ. Res. 79 (1996) 256-262
22. Davisson R.L., Possas O.S., Murphy S.P., and Lewis S.J. Neurogenically-derived nitrosyl factors mediate lumbar sympathetic vasodilation in the hindlimb vasculature of the rat. Am. J. Physiol. 272 (1997) H2369-H2376
23. Davisson R.L., Travis M.D., Bates J.N., Johnson A.K., and Lewis S.J. Stereoselective actions of S-nitrosocysteine in the central nervous system of conscious rats. Am. J. Physiol. 272 (1997) H2361-H2368
24. de Champlain J., Wu R., Girouard H., Karas M., El Midaoui A., Laplante M.A., and Wu L. Oxidative stress in hypertension. Clin. Exp. Hypertens. 26 (2004) 593-601
25. Fukuda N., Izumi Y., Minato M., Soma M., Watanabe Y., Watanabe M., and Hatano M. Cyclic GMP formation of resistance vessel in the development of hypertension in spontaneously hypertensive rats. Jpn. Circ. J. 55 (1991) 721-728
26. Graves J.E., Bates J.N., Kooy N.W., and Lewis S.J. Vasodilator actions of the endothelium-derived relaxing factor l-S-nitrosocysteine in anesthetized rats are markedly diminished by peroxynitrite. Clin. Exp. Physiol. Pharmacol. 32 (2005) 1137-1141
27. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106 (1980) 207-212
28. Haywood J.R., Shaffer R.A., Fastenow C., Fink G.D., and Brody M.J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rats. Am. J. Physiol. 241 (1981) H273-H278
29. Hoque A., Bates J.N., and Lewis S.J. In vivo evidence that l-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature. Eur. J. Pharmacol. 384 (1999) 169-172
30. Hoque A., Bates J.N., and Lewis S.J. Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo. Eur. J. Pharmacol. 408 (2000) 195-198
31. Hughes D.B., and Britton M.L. Angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Pharmacotherapy 25 (2005) 1602-1620
32. Ito H., Torii M., and Suzuki T. A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp. Biochem. Physiol. 103 (1992) 37-40
33. Janssen L.J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am. J. Physiol. 280 (2001) L1067-L1082
34. Jourd'heuil D., Hallen K., Feelisch M., and Grisham M.B. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic. Biol. Med. 28 (2000) 409-417
35. Kahonen M., Makynen H., Wu X., Arvola P., and Porsti I. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment. Brit. J. Pharmacol. 115 (1995) 859-867
36. Kakuyama M., Vallance P., and Ahluwalia A. Endothelium-dependent sensory NANC vasodilatation: involvement of ATP, CGRP and a possible NO store. Brit. J. Pharmacol. 123 (1998) 310-316
37. + channels in the regulation of basilar arterial tone in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 29 (2002) 575-581
38. Kerr S., Brosnan M.J., McIntyre M., Reid J.L., Dominiczak A.F., and Hamilton C.A. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33 (1999) 1353-1358
39. Konishi M., and Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5 (1983) 881-886
40. Kowaluk E.A., and Fung H. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 25 (1990) 1256-1264
41. Krysztopik R.J., Matheson P.J., Spain D.A., Garrison R.N., and Wilson M.A. Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J. Surg. Res. 93 (2000) 75-81
42. Landar A., Oh J.Y., Giles N.M., Isom A., Kirk M., Barnes S., and Darley-Usmar V.M. A sensitive method for the quantitative measurement of protein thiol modification in response to oxidative stress. Free Radic. Biol. Med. 40 (2006) 59-468
43. Ca) channels in myocytes of the guinea-pig taenia caeca. Brit. J. Pharmacol. 139 (2003) 1153-1163
44. Lappas G., Daou G.B., and Anand-Srivastava M.B. Oxidative stress contributes to the enhanced expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J. Hypertens. 23 (2005) 2251-2261
45. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., and Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 (1997) 588-593
46. Lazaro A., Gallego-Delgado J., Justo P., Esteban V., Osende J., Mezzano S., Ortiz A., and Egido J. Long-term blood pressure control prevents oxidative renal injury. Antioxid. Redox Signal. 7 (2005) 1285-1293
47. Lewis S.J., Travis M.D., and Bates J.N. Stereoselective S-nitrosocysteine recognition sites in rat brain. Eur. J. Pharmacol. 312 (1996) R3-R5
48. Lewis S.J., Graves J.E., Bates J.N., and Kooy N.W. Peroxynitrite elicits dysfunction of stereoselective S-nitrosocysteine recognition sites. J. Cardiovasc. Pharmacol. 46 (2005) 637-645
49. Lewis S.J., Hoque A., and Bates J.N. Differentiation of l- and d-S-nitrosothiol recognition sites. J. Cardiovasc. Pharmacol. 46 (2005) 660-671
50. Lewis S.J., Bhopatkar M.Y., Walton T.M., and Bates J.N. Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats. Eur. J. Pharmacol. 528 (2005) 144-149
51. Lewis S.J., Hashmi-Hill M.P., Owen J.R., Sandock K., Robertson T.P., and Bates J.N. The vasodilator potency of the endothelium-derived relaxing factor, l-S-nitrosocysteine, is impaired in conscious Spontaneously Hypertensive rats. Vasc. Pharm. 44 (2006) 476-490
52. Li X., Rose G., Dongre N., Pan H.L., Tobin J.R., and Eisenach J.C. S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes. Brain Res. 72 (2000) 301-307
53. Lipton S.A., Choi Y., Pan Z., Lei S.Z., Chen H.V., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1364 (1993) 626-632
54. Lipton A.J., Johnson M.A., Macdonald T., Lieberman M.W., Gozal D., and Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature 413 (2001) 171-174
55. Loyaga-Rendon R.Y., Sakamoto S., Aso T., Iwasaki-Kurashige K., Takahashi R., and Azuma H. Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model. J. Pharmacol. Sci. 98 (2005) 263-274
56. Luscher T.F., and Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8 (1986) 344-348
57. Luscher T.F., Aarhus L.L., and Vanhoutte P.M. Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the Spontaneously Hypertensive Rat. Am. J. Hypertens. 3 (1990) 55-58
58. Mathews R.W., and Kerr SW. Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267 (1993) 1529-1537
59. Mayhan W.G., Faraci F.M., and Heistad D.D. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am. J. Physiol. 253 (1987) H1435-H1440
60. Mayhan W.G., Faraci F.M., and Heistad D.D. Responses of cerebral arterioles to adenosine diphosphate, serotonin and the thromboxane analogue U-46619 during chronic hypertension. Hypertension 12 Suppl 6 (1989) 556-557
61. Moncada S., Higgs E.A., and Palmer R.M.J. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
62. Muller B., Kleschyov A.L., Alencar J.L., Vanin A., and Stoclet J.C. Nitric oxide transport and storage in the cardiovascular system. Ann. N.Y. Acad. Sci. 962 (2002) 131-139
63. Myers P.R., Minor Jr. R.L., Guerra Jr. R., Bates J.N., and Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345 (1990) 161-163
64. Nozik-Grayck E., McMahon T.J., Huang Y.C., Dieterle C.S., Stamler J.S., and Piantadosi C.A. Pulmonary vasoconstriction by serotonin is inhibited by S-nitrosoglutathione. Am. J. Physiol. 282 (2002) L1057-L1065
65. 1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. Am. J. Physiol. 290 (2006) L136-L143
66. Ohmori M., and Fujimura A. ACE inhibitors and chronotherapy. Clin. Exp. Hypertens. 27 (2005) 179-185
67. Phillips K., Gardiner S.M., Kemp P.A., and Bennet T. Factors affecting the regional hemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats. Brit. J. Pharmacol. 104 (1991) 151-158
68. Possas O., Johnson A.K., and Lewis S.J. Role of nitrosyl factors in the hindlimb vasodilation produced by baroreceptor afferent nerve stimulation. Am. J. Physiol. 290 (2006) R741-R748
69. Roberts L.J., and Morrow J.D. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28 (2000) 505-513
70. Rosenblum W.I. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke 23 (1992) 1527-1532
71. Rozsa Z., and Sonkodi S. The effect of long-term oral captopril treatment on mesenteric blood flow in spontaneously hypertensive rats. Pharmacol. Res. 32 (1995) 21-25
72. Schnackenberg C.G., Welch W.J., and Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with membrane permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32 (1998) 59-64
73. Schnackenberg C., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F2α. Hypertension 33 (1999) 424-428
74. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
75. Stamler J.S., Singel D.J., and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258 (1992) 1898-1902
76. Stamler J.S., Toone E.J., Lipton S.A., and Sucher N.J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18 (1997) 691-696
77. Stys T., Stys A., Paczwa P., Szczepanska-Sadowska E., and Lipkowski A.W. Decreased hypotensive responsiveness to nitric oxide donor S-nitroso N-acetyl-dl-penicillamine (SNAP) in spontaneously hypertensive (SHR) rats. J. Physiol. Pharmacol. 49 (1998) 37-49
78. Tanaka M., Umemoto S., Kawahara S., Kubo M., Itoh S., Umeji K., and Matsuzaki M. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens. Res. 28 (2005) 67-77
79. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 44 (2004) 248-252
80. Travis M.D., and Lewis SJ. Apparent association of MK-801-sensitive ion-channels with l-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat. Eur. J. Pharmacol. 407 (2000) 309-312
81. Travis M.D., Stoll L.L., Bates J.N., and Lewis S.J. l- and d-S-nitroso-β,β-dimethylcysteine differentially increase cGMP in vascular smooth muscle. Eur. J. Pharmacol. 318 (1996) 47-53
82. Travis M.D., Davisson R.L., Bates J.N., and Lewis S.J. Hemodynamic effects of l- and d-S-nitroso-β,β-dimethylcysteine in the rat. Am. J. Physiol. 273 (1997) H1493-H1501
83. 2+ -channels markedly diminishes nitric oxide- but not l-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo. Eur. J. Pharmacol. 408 (2000) 289-298
84. Tschudi M.R., Criscione L., Novosel D., Pfeiffer K., and Luscher T.F. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation 89 (1994) 2212-2218
85. Ungvari Z., Cziszar A., Kamininski P.M., Wolin M.S., and Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am. J. Pathol. 165 (2004) 219-226
86. Vanin A.F. Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems. Biochemistry 63 (1998) 782-793
87. Vericel E., Narce M., Ulmann L., Poisson J.P., and Lagarde M. Age-related changes in antioxidant defense mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol. Cell Biochem. 132 (1994) 25-29
88. Welch W.J., Mendonca M., Blau J., Karber A., Dennehy K., Patel K., Lao Y.S., Jose P.A., and Wilcox C.S. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int. 68 (2005) 179-187
89. Widdop R.E., Verberne A.J.M., Jarrott B., and Louis W.J. Impaired arterial baroreceptor reflex and cardiopulmonary vagal reflex in conscious spontaneously hypertensive rats. J. Hypertens. 8 (1990) 269-275
90. Wiemer G., Linz W., Hatrik S., Scholkens B.A., and Malinski T. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 30 (1997) 1183-1190
91. Wilson S.K. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ. Res. 66 (1990) 722-734
92. + channels to acetylcholine-induced dilatation of rat conduit and resistance arteries. Clin. Exp. Pharmacol. Physiol. 27 (2000) 34-40
93. Yanes L., Romero D., Iliescu R., Cucchiarelli V.E., Fortepiani L.A., Santacruz F., Bell W., Zhang H., and Reckelhoff J.F. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am. J. Physiol. 288 (2005) R903-R908
94. Yuan Y.V., Kitts D.D., and Godin D.V. Heart and red blood cell antioxidant status and plasma lipid levels in the spontaneously hypertensive and normotensive Wistar-Kyoto rat. Can. J. Physiol. Pharmacol. 74 (1996) 290-297
95. Zhang X.M., and Ellis E.F. Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am. J. Physiol. 259 (1990) H497-H503